Favorable outcomes of NPM1(mut) AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance
NPM1(突变) AML患者的良好预后归因于FOXM1的转录失活,这为克服化疗耐药性提供了一个新的靶点。
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-023-00898-4
Khan, I; Kaempf, A; Raghuwanshi, S; Chesnokov, M; Zhang, X; Wang, Z; Domling, A; Tyner, J W; Camacho, C; Gartel, A L